Abstract: Lymph node metastasis (LNM) is a crucial risk factor influencing an unfavorable prognosis in specific cancers. Fundamental research illuminates our understanding of tumor behavior and identifies valuable therapeutic targets. Nevertheless, the exploration of fundamental theories and the validation of clinical therapies hinge on preclinical experiments. Preclinical models, in this context, serve as the conduit connecting fundamental theories to clinical outcomes. In vivo models established in animals offer a valuable platform for comprehensively observing interactions between tumor cells and organisms. Using various experimental animals, including mice, diverse methods, such as carcinogen-induced tumorigenesis, tumor cell line or human tumor transplantation, genetic engineering, and humanization, have been used effectively to construct numerous models for tumor LNM. Carcinogen-induced models simulate the entire process of tumorigenesis and metastasis. Transplantation models, using human tumor cell lines or patient-derived tumors, offer a research platform closely mirroring the histology and clinical behavior of human tumors. Genetically engineered models have been used to delve into the mechanisms of primary tumorigenesis within an intact microenvironment. Humanized models are used to overcome barriers between human and murine immune systems. Beyond mouse models, various other animal models have unique advantages and limitations, all contributing to exploring LNM. This review summarizes existing in vitro and animal preclinical models, identifies current bottlenecks in preclinical research, and offers an outlook on forthcoming preclinical models.

淋巴结转移研究中的临床前模型

[1]AliOA, HuebschN, CaoL, et al., 2009. Infection-mimicking materials to program dendritic cells in situ. Nat Mater, 8(2):151-158.

[2]AliZ, VildevallM, RodriguezGV, et al., 2022. Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer. J Exp Clin Cancer Res, 41:58.

[3]AlmogueraC, ShibataD, ForresterK, et al., 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53(4):549-554.

[4]Al-SamadiA, PoorB, TuomainenK, et al., 2019. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients. Exp Cell Res, 383(2):111508.

[5]AnastasJN, MoonRT, 2013. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer, 13(1):11-26.

[6]AytesA, GiacobbeA, MitrofanovaA, et al., 2018. NSD2 is a conserved driver of metastatic prostate cancer progression. Nat Commun, 9:5201.

[7]BaekAE, 2022. Lymph node colonization and metastasis. Sci Signal, 15(734):eadc9985.

[8]BhinderB, GilvaryC, MadhukarNS, et al., 2021. Artificial intelligence in cancer research and precision medicine. Cancer Discov, 11(4):900-915.

[9]BondarenkoG, UgolkovA, RohanS, et al., 2015. Patient-derived tumor xenografts are susceptible to formation of human lymphocytic tumors. Neoplasia, 17(9):735-741.

[10]BouchlakaMN, SckiselGD, ChenM, et al., 2013. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med, 210(11):2223-2237.

[11]BrycePJ, FalahatiR, KenneyLL, et al., 2016. Humanized mouse model of mast cell‒mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis. J Allergy Clin Immunol, 138(3):769-779.

[12]CaoXQ, ShoresEW, Hu-LiJ, et al., 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity, 2(3):223-238.

[13]ChappazS, FinkeD, 2010. The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes. J Immunol, 184(7):3562-3569.

[14]ChenM, ShanH, TaoQ, et al., 2024. Mimicking tumor metastasis using a Transwell-integrated organoids-on-a-chip platform. Small, 20(27):e2308525.

[15]ChoiYY, LeeJE, KimH, et al., 2016. Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer. Sci Rep, 6:22172.

[16]ChuprinJ, BuettnerH, SeedhomMO, et al., 2023. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol, 20(3):192-206.

[17]CiampricottiM, HauCS, DoornebalCW, et al., 2012. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system. Nat Med, 18(3):344-346.

[18]ComanDR, EisenbergRB, McCutcheonM, 1949. Factors affecting the distribution of tumor metastases; experiments with V2 carcinoma of rabbits. Cancer Res, 9(11):649-651.

[19]CooperCR, ChayCH, GendernalikJD, et al., 2003. Stromal factors involved in prostate carcinoma metastasis to bone. Cancer, 97(S3):739-747.

[20]CorsoS, CargneluttiM, DurandoS, et al., 2018. Rituximab treatment prevents lymphoma onset in gastric cancer patient-derived xenografts. Neoplasia, 20(5):443-455.

[21]DankortD, CurleyD, CartlidgeR, et al., 2009. Braf^V600E cooperates with Pten loss to induce metastatic melanoma. Nat Genet, 41(5):544-552.

[22]de WeverO, MareelM, 2003. Role of tissue stroma in cancer cell invasion. J Pathol, 200(4):429-447.

[23]DentonPW, NochiT, LimA, et al., 2012. IL-2 receptor γ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice. Mucosal Immunol, 5(5):555-566.

[24]DongHM, LinW, DuL, et al., 2023. PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET. Cancer Lett, 567:216283.

[25]ElementoO, LeslieC, LundinJ, et al., 2021. Artificial intelligence in cancer research, diagnosis and therapy. Nat Rev Cancer, 21(12):747-752.

[26]Estrela-LimaA, AraújoMSS, Costa-NetoJM, et al., 2010. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer, 10:256.

[27]EswarakaJ, GiddabasappaA, 2017. Humanized mice and PDX models. In: Uthamanthil R, Tinkey P (Eds.), Patient Derived Tumor Xenograft Models. Academic Press, London, p.75-89.

[28]FreseKK, TuvesonDA, 2007. Maximizing mouse cancer models. Nat Rev Cancer, 7(9):654-658.

[29]FridmanWH, PagèsF, Sautès-FridmanC, et al., 2012. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer, 12(4):298-306.

[30]FuX, GuadagniF, HoffmanRM, 1992. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA, 89(12):5645-5649.

[31]FuX, TheodorescuD, KerbelRS, et al., 1991. Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice. Int J Cancer, 49(6):938-939.

[32]FurukawaT, KubotaT, WatanabeM, et al., 1993. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer, 53(4):608-612.

[33]GopinathanA, MortonJP, JodrellDI, et al., 2015. GEMMs as preclinical models for testing pancreatic cancer therapies. Dis Model Mech, 8(10):1185-1200.

[34]HayakawaT, FurusawaT, YamashitaH, 1986. A comparative anatomical study of the lymphatic system of the lung in mammals: 5. Findings in rodentia. Okajimas Folia Anat Jpn, 63(2-3):73-79.

[35]HewsonW, 1769. XXIX. An account of the lymphatic system in fish. By the same. Philos Trans, 59:204-215.

[36]HeyerJ, KwongLN, LoweSW, et al., 2010. Non-germline genetically engineered mouse models for translational cancer research. Nat Rev Cancer, 10(7):470-480.

[37]HingoraniSR, WangLF, MultaniAS, et al., 2005. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell, 7(5):469-483.

[38]HoadleyKA, YauC, HinoueT, et al., 2018. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell, 173(2):291-304.e296.

[39]HoferM, LutolfMP, 2021. Engineering organoids. Nat Rev Mater, 6(5):402-420.

[40]HrubanRH, Iacobuzio-DonahueC, WilentzRE, et al., 2001. Molecular pathology of pancreatic cancer. Cancer J, 7(4):251-258.

[41]JeonJS, BersiniS, GilardiM, et al., 2015. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci USA, 112(1):214-219.

[42]JiHR, HuC, YangXH, et al., 2023. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Ther, 8:367.

[43]JinWL, LiangZ, ZhouXJ, et al., 2008. Establishment of a highly metastatic tongue squamous cell carcinoma cell line from New Zealand White rabbit. Arch Oral Biol, 53(11):1084-1090.

[44]JonesGW, HillDG, JonesSA, 2016. Understanding immune cells in tertiary lymphoid organ development: it is all starting to come together. Front Immunol, 7:401.

[45]KerbelRS, 2003. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived—but they can be improved. Cancer Biol Ther, 2(S1):133-138.

[46]KerstenK, deVisser KE, van MiltenburgMH, et al., 2016. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med, 9(2):137-153.

[47]KhannaC, HunterK, 2005. Modeling metastasis in vivo. Carcinogenesis, 26(3):513-523.

[48]KillionJJ, RadinskyR, FidlerIJ, 1998. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev, 17(3):279-284.

[49]KimS, ShahSB, GraneyPL, et al., 2019. Multiscale engineering of immune cells and lymphoid organs. Nat Rev Mater, 4(6):355-378.

[50]KimSK, KimYH, ParkS, et al., 2021. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling. Acta Biomater, 132:37-51.

[51]KimmelmanJ, AndersonJA, 2012. Should preclinical studies be registered? Nat Biotechnol, 30(6):488-489.

[52]KobayashiY, WatanabeT, 2016. Gel-trapped lymphorganogenic chemokines trigger artificial tertiary lymphoid organs and mount adaptive immune responses in vivo. Front Immunol, 7:316.

[53]KongY, LiYT, LuoYM, et al., 2020. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer. Mol Cancer, 19:82.

[54]KuTKS, NguyenDC, KaramanM, et al., 2007. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res, 5(4):351-362.

[55]KubotaT, 1994. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem, 56(1):4-8.

[56]LangJL, KellyM, FreedBM, et al., 2013. Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J Immunol, 190(5):2090-2101.

[57]LeeJY, ChoiBI, SonKR, et al., 2012. Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model. Radiology, 263(2):391-400.

[58]LiJ, LiangFX, YuDH, et al., 2013. Development of a 4-nitroquinoline-1-oxide model of lymph node metastasis in oral squamous cell carcinoma. Oral Oncol, 49(4):299-305.

[59]LiY, Masse-RansonG, GarciaZ, et al., 2018. A human immune system mouse model with robust lymph node development. Nat Methods, 15(8):623-630.

[60]LinD, WyattAW, XueH, et al., 2014. High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development. Cancer Res, 74(4):1272-1283.

[61]MermodM, Hiou-FeigeA, BovayE, et al., 2018. Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer. Int J Cancer, 142(12):2518-2528.

[62]MestasJ, HughesCCW, 2004. Of mice and not men: differences between mouse and human immunology. J Immunol, 172(5):2731-2738.

[63]Mouse Genome Sequencing Consortium, 2002. Initial sequencing and comparative analysis of the mouse genome. Nature, 420(6915):520-562.

[64]MuhannaN, JinCS, HuynhE, et al., 2015. Phototheranostic porphyrin nanoparticles enable visualization and targeted treatment of head and neck cancer in clinically relevant models. Theranostics, 5(12):1428-1443.

[65]MurayamaT, GotohN, 2019. Patient-derived xenograft models of breast cancer and their application. Cells, 8(6):621.

[66]MurookaTT, DeruazM, MarangoniF, et al., 2012. HIV-infected T cells are migratory vehicles for viral dissemination. Nature, 490(7419):283-287.

[67]NassarD, LatilM, BoeckxB, et al., 2015. Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat Med, 21(8):946-954.

[68]National Institutes of Health, 2025. Guidelines for Humane Endpoints in Animal Study Proposals. https://oacu.oir.nih.gov/system/files/media/file/2025-04/b13_endpoints_guidelines.pdf

[69]OhtakeK, ShingakiS, NakajimaT, 1993. Histologic study on the metastatic process in the experimental model of lymph node metastasis. Oral Surg Oral Med Oral Pathol, 75(4):472-478.

[70]OkudaKS, LeeHM, VelaithanV, et al., 2016. Utilizing zebrafish to identify anti-(lymph)angiogenic compounds for cancer treatment: promise and future challenges. Microcirculation, 23(6):389-405.

[71]OshiroH, 2014. The role of the lymphatic system in rabbit models for cancer metastasis research: a perspective from comparative anatomy. Okajimas Folia Anat Jpn, 91(2):25-28.

[72]OstrowRS, McGlennenRC, ShaverMK, et al., 1990. A rhesus monkey model for sexual transmission of a papillomavirus isolated from a squamous cell carcinoma. Proc Natl Acad Sci USA, 87(20):8170-8174.

[73]OvergaardNH, FanTM, SchachtschneiderKM, et al., 2018. Of mice, dogs, pigs, and men: choosing the appropriate model for immuno-oncology research. ILAR J, 59(3):247-262.

[74]PascualG, AvgustinovaA, MejettaS, et al., 2017. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature, 541(7635):41-45.

[75]Pérez-GuijarroE, DayCP, MerlinoG, et al., 2017. Genetically engineered mouse models of melanoma. Cancer, 123(S11):2089-2103.

[76]Perez-LopezR, Ghaffari LalehN, MahmoodF, et al., 2024. A guide to artificial intelligence for cancer researchers. Nat Rev Cancer, 24(6):427-441.

[77]PerrinS, 2014. Preclinical research: make mouse studies work. Nature, 507(7493):423-425.

[78]PontiusJU, MullikinJC, SmithDR, et al., 2007. Initial sequence and comparative analysis of the cat genome. Genome Res, 17(11):1675-1689.

[79]QueirogaFL, RaposoT, CarvalhoMI, et al., 2011. Canine mammary tumours as a model to study human breast cancer: most recent findings. In Vivo, 25(3):455-465.

[80]RahimMK, OkholmTLH, JonesKB, et al., 2023. Dynamic CD8⁺ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell, 186(6):1127-1143.e18.

[81]RashidiB, GamagamiR, SassonA, et al., 2000. An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. Clin Cancer Res, 6(6):2556-2561.

[82]RennertPD, JamesD, MackayF, et al., 1998. Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity, 9(1):71-79.

[83]Reticker-FlynnNE, ZhangWR, BelkJA, et al., 2022. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell, 185(11):1924-1942.e23.

[84]RongvauxA, TakizawaH, StrowigT, et al., 2013. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol, 31:635-674.

[85]RygaardJ, PoulsenCO, 1969. Heterotransplantation of a human malignant tumour to “nude” mice. Acta Pathol Microbiol Scand, 77(4):758-760.

[86]SanoD, MyersJN, 2009. Xenograft models of head and neck cancers. Head Neck Oncol, 1:32.

[87]SavanNA, SaavedraPV, HalimA, et al., 2022. Case report: microRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials. Front Oncol, 12:959630.

[88]SchlangeT, MatsudaY, LienhardS, et al., 2007. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res, 9(5):R63.

[89]Schmidt-HansenB, KlingelhöferJ, Grum-SchwensenB, et al., 2004. Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J Biol Chem, 279(23):24498-24504.

[90]SchwitallaS, ZieglerPK, HorstD, et al., 2013. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell, 23(1):93-106.

[91]SeokJ, WarrenHS, CuencaAG, et al., 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA, 110(9):3507-3512.

[92]SharkeyFE, FoghJ, 1979. Metastasis of human tumors in athymic nude mice. Int J Cancer, 24(6):733-738.

[93]SharmaG, GoyalY, BhatiaS, 2023. Preclinical animal models of cancer: applications and limitations. In: Pathak S, Banerjee A, Bisgin A (Eds.), Handbook of Animal Models and Its Uses in Cancer Research. Springer, Singapore, p.1051-1071.

[94]ShiYW, XieTX, WangBB, et al., 2022. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Commun Biol, 5:757.

[95]ShibataH, ToyamaK, ShioyaH, et al., 1997. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science, 278(5335):120-123.

[96]ShultzLD, IshikawaF, GreinerDL, 2007. Humanized mice in translational biomedical research. Nat Rev Immunol, 7(2):118-130.

[97]ShultzLD, BrehmMA, Garcia-MartinezJV, et al., 2012. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol, 12(11):786-798.

[98]SinghA, QinH, FernandezI, et al., 2011. An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma. J Controlled Release, 155(2):184-192.

[99]SovakM, 1984. Contrast media in lymphography. In: Sovak M (Ed.), Radiocontrast Agents. Springer, Berlin, Heidelberg, p.463-477.

[100]SpenléC, LoustauT, BurckelH, et al., 2021. Impact of tenascin-C on radiotherapy in a novel syngeneic oral squamous cell carcinoma model with spontaneous dissemination to the lymph nodes. Front Immunol, 12:636108.

[101]SuggittM, BibbyMC, 2005. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches. Clin Cancer Res, 11(3):971-981.

[102]SunZF, DentonPW, EstesJD, et al., 2007. Intrarectal transmission, systemic infection, and CD4⁺ T cell depletion in humanized mice infected with HIV-1. J Exp Med, 204(4):705-714.

[103]SupsavhadW, DirksenWP, MartinCK, et al., 2016. Animal models of head and neck squamous cell carcinoma. Vet J, 210:7-16.

[104]TakahashiT, KatanoI, ItoR, et al., 2018. Enhanced antibody responses in a novel NOG transgenic mouse with restored lymph node organogenesis. Front Immunol, 8:2017.

[105]TaoLL, ReeseTA, 2017. Making mouse models that reflect human immune responses. Trends Immunol, 38(3):181-193.

[106]TasoulasJ, SrivastavaS, XuXN, et al., 2023. Genetically engineered mouse models of head and neck cancers. Oncogene, 42(35):2593-2609.

[107]TheocharidesAPA, RongvauxA, FritschK, et al., 2016. Humanized hemato-lymphoid system mice. Haematologica, 101(1):5-19.

[108]ThordarsonG, LeeAV, McCartyM, et al., 2001. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis, 22(12):2039-2047.

[109]TormoD, FerrerA, GaffalE, et al., 2006. Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. Am J Pathol, 169(2):665-672.

[110]van DooijeweertC, FlachRN, ter HoeveND, et al., 2024. Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial. Nat Cancer, 5:1195-1205.

[111]VargaJ, NicolasA, PetrocelliV, et al., 2020. AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer. J Exp Med, 217(10):e20191515.

[112]VentreKS, KarakousiT, LundAW, 2022. Lymph node metastasis fuels systemic disease. Trends Cancer, 8(8):623-625.

[113]VuyyuruR, PattonJ, ManserT, 2011. Human immune system mice: current potential and limitations for translational research on human antibody responses. Immunol Res, 51(2-3):257-266.

[114]WadmanM, 2023. FDA no longer has to require animal testing for new drugs. Science, 379(6628):127-128.

[115]WangH, NingXF, ZhaoF, et al., 2024. Human organoids-on-chips for biomedical research and applications. Theranostics, 14(2):788-818.

[116]WangJ, MileticH, SakariassenPØ, et al., 2009. A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer, 9:465.

[117]WangJP, SiTG, ZhangYT, et al., 2012. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity. J Magn Reson Imaging, 36(3):624-631.

[118]WangZY, WuVH, AllevatoMM, et al., 2019. Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nat Commun, 10:5546.

[119]WeeseJL, StarlingJR, TurnerJH, 1983. Development of a carcinogen-induced rat colon cancer with lymph-node metastases. Dis Colon Rectum, 26(9):573-577.

[120]WeijerK, HeadKW, MisdorpW, et al., 1972. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst, 49(6):1697-1704.

[121]WischnitzerS, 2006. Atlas and Dissection Guide for Comparative Anatomy. W. H. Freeman, New York, USA.

[122]YangL, ZhangSE, LiJS, et al., 2025. Diagnosis of lymph node metastasis in oral squamous cell carcinoma by an MRI-based deep learning model. Oral Oncol, 161:107165.

[123]ZhongLP, HuangY, HeJ, et al., 2021. Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver. Signal Transduct Target Ther, 6:411.

[124]ZhuGY, FalahatR, WangK, et al., 2017. Tumor-associated tertiary lymphoid structures: gene-expression profiling and their bioengineering. Front Immunol, 8:767.

[125]ZhuJL, JiLL, ChenYT, et al., 2023. Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer. Cell Death Discov, 9:72.

[126]ZitvogelL, PittJM, DaillèreR, et al., 2016. Mouse models in oncoimmunology. Nat Rev Cancer, 16(12):759-773.